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Absence of  
Rift Valley Fever 
Virus in Wild Small 
Mammals,  
Madagascar
To the Editor: Rift Valley fever 
virus (RVFV) is a mosquito-borne 
zoonotic virus in the family Bunya-
viridae, genus Phlebovirus, which af-
fects mainly domestic ruminants and 
humans on continental Africa, Mada-
gascar, and the Arabian Peninsula (1). 
RVFV is transmitted between rumi-
nants mainly by bites of mosquitoes of 
several genera (1). Infection can lead 
to mild symptoms or can cause abor-
tion in pregnant animals and high mor-
tality rates among newborns. Humans 
are mostly infected by aerosol trans-
mission when handling infected tissues 
(aborted fetuses or meat), which results 
in dengue-like illness. Some cases in 
humans can be in a severe form (hem-
orrhagic fever and meningoencephali-
tis), which can be fatal. Outbreaks in 
southern and eastern Africa are associ-
ated with periods of heavy rainfall (1). 
In eastern Africa, RVFV is believed to 
be maintained during interepizootic 
periods through vertical transmission 
in Aedes spp. mosquitoes (1). It has 
been suspected that wild mammals, 
especially rodents, play a role in the 
maintenance of RVFV during interepi-
zootic periods (2). However, evidence 
of a wild mammal reservoir in the epi-
demiologic cycle of RVFV has yet to 
be demonstrated (2).
In Madagascar, the first RVFV 
isolate was obtained from mosquitoes 
captured in the Périnet Forest (Anda-
sibe, Moramanga District) in 1979, 
outside an epizootic period (3). Two 
epizootic episodes occurred, during 
1990–91 and 2008–09 (4). After the 
most recent episode, domestic rumi-
nants were shown to be involved in 
RVFV circulation during interepizo-
otic periods (5,6); together with the 
potential vertical transmission in Ae-
des spp. mosquitoes in Madagascar, 
they might play a role in the mainte-
nance of RVFV. However, genetic evi-
dence indicates that RVFV outbreaks 
in Madagascar are not associated with 
emergence from enzootic cycles but 
that they are associated with recur-
rent virus introductions from main-
land east Africa (7). Although these 
mechanisms for RVFV epidemiology 
on Madagascar are documented, the 
possibility of a wild mammal reser-
voir cannot be excluded. We therefore 
explored the role of wild terrestrial 
small mammals in the maintenance of 
RVFV in Madagascar, especially the 
nonnative, abundant, and ubiquitous 
black rats (Rattus rattus) (8), as has 
been suggested in rural Egypt (9,10).
For this study, 1,610 blood sam-
ples were obtained from different spe-
cies of wild terrestrial small mammals 
in Madagascar (Figure). Permits to 
capture and collect animals were ob-
tained from national authorities. Ani-
mals were sampled from October 2008 
through March 2010 at a site in the 
Anjozorobe-Angavo (Anjozorobe Dis-
trict) forest corridor (18°18′′41.9′ S, 
48°00′′57.6′ E), where RVFV was first 
detected in humans and cattle in Febru-
ary 2008 (4) and within 100 km from 
where the first RVFV was isolated in 
1979 (3). We collected 378 serum sam-
ples from 11 native Tenrecidae (Af-
rosoricida) tenrecs, 114 samples from 6 
native Nesomyidae (Rodentia) rodents, 
and 471 samples from introduced R. 
Rattus (Muridae, Rodentia) rats (online 
Technical Appendix, wwwnc.cdc.gov/
EID/article/19/6/12-1074-Techapp1.
pdf). In addition, during 2008, we ob-
tained serum samples from 647 R. rat-
tus or R. norvegicus rats living near 
humans in areas where RVFV was 
reportedly circulating during 2008 and 
2009: the districts of Ankazobe, An-
tsiranana, Betafo, Ihosy, Marovoay, 
and Moramanga (4,5) (Figure).
Serum samples were tested for 
IgG against RVFV by ELISA, as 
described (4), by using peroxidase-
labeled recombinant protein A/G 
(Pierce, Rockford, IL, USA) or 
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anti-mouse or rat IgG (H+L) accord-
ing to the ability to recognize the im-
munoglobulin of species endemic to 
Madagascar (data not shown). The 
results were negative for all samples 
tested. Liver and spleen samples from 
947 animals caught in the Anjozo-
robe-Angavo forest corridor were also 
tested. Approximately 50–100 mg of 
liver and spleen from each individual 
was mixed and homogenized at a di-
lution of 1:10 in culture medium con-
taining 40% fetal bovine serum. After 
centrifugation, supernatants were col-
lected and pooled by species (maxi-
mum 5 individuals/pool). RNA was 
extracted from pooled supernatants by 
using TRIzol LS reagent (Invitrogen, 
Carlsbad, CA, USA) according to the 
manufacturers’ instructions. Detec-
tion of RVFV RNA was attempted by 
using real-time reverse transcription 
PCR (4). The results were negative for 
the 220 monospecific pools tested.
Serologic and virologic results 
from rodent and tenrec samples col-
lected during and after the epizootic 
2008–2009 periods were negative for 
RVFV; 72.8% had been collected in 
municipalities where RVFV cases 
were reported. This finding does not 
indicate a role of native Rodentia and 
Afrosoricida mammals in the epide-
miology of RVFV in Madagascar, nor 
does it indicate evidence of infection 
of Rattus spp. rats, as suggested in 
Egypt (9,10). The absence of infec-
tion in Rattus spp. rats during a period 
of intense RVFV circulation does not 
support its potential role during the 
outbreak and, a fortiori, in the main-
tenance of RVFV during interepizo-
otic periods. Among wild terrestrial 
mammals in Madagascar, animals of 
the orders Carnivora and Primata are 
not considered as candidates for the 
maintenance of RVFV; however, bats 
(order Chiroptera) and introduced 
bushpigs (order Artiodactyla , family 
Suidae, genus Potamochoerus) could 
be candidates, and their role in RVFV 
maintenance should be investigated 
(2). At present, no evidence is avail-
able for the maintenance of RVFV in 
wild terrestrial small mammals (na-
tive and introduced) in Madagascar.
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Colostrum Replacer 
and Bovine  
Leukemia Virus  
Seropositivity  
in Calves
To the Editor: Bovine leukemia 
virus (BLV), a deltaretrovirus in the 
family Retroviridae, is the causative 
agent of enzootic bovine leukosis 
(EBL). Although EBL is still endemic 
to the Americas and eastern Europe, 
most countries in western Europe are 
EBL free in accordance with European 
Union legislation; for example, Great 
Britain has held EBL-free status since 
1999. EBL is notifiable to the World 
Organisation for Animal Health (1), 
with disease incursion affecting inter-
national trade. Infection with BLV is 
life-long and persistent; the presence of 
antibodies or integrated proviral DNA 
are indicators of virus exposure. Two 
tests prescribed for international trade 
are the agar gel immunodiffusion test 
(AGIDT) and ELISA (1); these tests 
are used widely for diagnosis (2). 
We report 5 cases that occurred in 
the United Kingdom during 2009, in 
which calves became seropositive for 
BLV after consuming colostrum replac-
er. In Dumfriesshire, Scotland, routine 
serologic screening for BLV detected 
seropositivity in 2 calves, which were 
artificial insemination bull candidates. 
In Newport, Wales, a BLV-seropositive 
calf was identified during pre-export 
testing. And in Yorkshire, England, 2 
more BLV-seropositive calves, also 
artificial insemination bull candidates, 
were identified. All calves were home 
bred, and there was no evidence (as 
documented by serologic testing) or 
history of EBL within the herd. The 
farms were considered to have low risk 
for disease incursion because the intro-
duction of new animals was limited. 
Further inquiry revealed that 
the calves had each been exclusively 
fed a colostrum replacer from North 
America, where BLV is endemic. 
Antibodies to BLV might have been 
present in the colostrum replacer and 
thus passively acquired by the calves, 
resulting in seropositivity. 
The hypothesis was tested by 
monthly blood sampling and ELISA 
analysis for antibodies against BLV 
(Institute Pourquier, Montpellier, 
France). Although the batch of colos-
trum replacer that had been fed to the 
calves from Dumfriesshire was not 
available for investigation, another 
colostrum sample was obtained from 
the same manufacturer for analysis. 
The reconstituted colostrum replacer 
was tested by AGIDT (IDEXX, Bern, 
Switzerland) at the following dilutions: 
neat (manufacturer’s guidelines), 1:2, 
1:4, and 1:8. In addition, 2 commer-
cial ELISA tests (Institute Pourquier 
and IDEXX) were used over a series 
of dilutions to 1:125. All serologic tests 
were conducted according to manufac-
turer’s recommendations. To examine 
the samples for proviral DNA, we con-
ducted PCRs to amplify a 385-bp frag-
ment of the envelope gene (3).
At the various dilutions of colos-
trum replacer, all serologic tests gave 
clearly positive reactions. Proviral PCR 
of the colostrum replacer also returned 
positive results, which were confirmed 
by sequencing. The resultant enve-
lope sequence (GenBank accession 
no. HF545344) was aligned with 23 
other sequences obtained from Gen-
Bank, which encompassed all known 
BLV genotypes. Phylogenetic analysis 
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